CVS vs REX · P/E 16, rev $402.07B vs P/E 15, rev $642.5M
CVS Health Corp (CVS) versus REX American Resources Corporation (REX) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
REX American Resources Corporation (REX) is a chemicals company listed on NYSE.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported REX revenue for 2025-01-31 was $642.5M. Net income was $71.5M. Revenue was down 22.9% from 2024-01-31 to 2025-01-31. REX currently screens at market cap $1.43B and trailing P/E 15.5.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. REX currently screens at market cap $1.43B and trailing P/E 15.5.
Not investment advice. Open the CVS and REX stock pages for the full models.
Not investment advice.